Medtronic plc (NYSE: MDT) today announced that the first patient has been enrolled in the IN.PACT(TM) AV Access Drug-Coated Balloon ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Medtronic, Inc. (MDT) PT Raised to $94 at BMO Capital on 4Q Beat; 'Strength Across Franchises'May 26, 2017 10:28 AM Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4QMay 26, 2017 9:52 AM Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight May 26, 2017 7:59 AM Medtronic, Inc. (MDT) PT Raised to $91 at Evercore ISI on Strong 4Q EPS/Revenue Results; 'Gross Margin Beat Despite Mix Shift'May 25, 2017 11:28 AM Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal DiseaseMay 24, 2017 12:14 PM